New Haven, Connecticut – As National Kidney Month raises awareness about kidney health, Dr. Julie Goodwin, pediatric nephrologist and Associate Professor at Yale School of Medicine, is highlighting promising new research aimed at improving care for children with kidney disease.
Dr. Goodwin and her research team are currently studying newly identified blood and urine biomarkers that may help doctors predict earlier which children with chronic kidney disease (CKD) are at higher risk of progressing to acute kidney injury (AKI).
Early detection is critical in pediatric kidney care, as it could allow physicians to intervene sooner and improve long-term health outcomes for young patients.
“This work is part of a broader effort to bring precision medicine approaches to pediatric kidney disease, which has historically been understudied compared with adult kidney disease,” said Dr. Goodwin.
She added that several large biomarker and multi-omics studies are currently underway, moving the field closer to identifying tools that could help personalize treatment and better predict disease progression in children.
Researchers believe that advances in biomarker discovery and precision medicine could significantly transform how pediatric kidney conditions are diagnosed and managed in the future, offering more targeted care and improved outcomes for young patients.
